C3893712||Mitotic entry
C2353787||Cdk1
C1579259||Polo-like kinase 1
C2353085||Bora
C1579259||Polo-like kinase 1
C1579259||Polo-like kinase 1
C0026255||mitotic
C0033640||kinase
C0026255||mitosis
C0012860||DNA damage
C1155873||cell cycle arrest
C1579259||Polo-like kinase 1
C0014429||activation
C0033684||protein
C2353085||Bora
C2975364||SPAT-1 in C. elegans
C1158886||phosphorylation
C0971285||Aurora A kinase
C1706852||article
C0684224||Cell Reports
C0033640||mitotic kinase
C2353787||Cdk1
C1579259||Polo-like kinase 1
C0014429||activation
C2975364||SPAT-1
C2353085||Bora
C1158886||phosphorylation
C0002520||Sp/Tp residues
C0449719||conserved part
C2975364||SPAT-1
C2353085||Bora
C1158886||Phosphorylation
C2353787||Cdk1
C1579259||Polo-like kinase 1
C3893712||mitotic entry
C0162610||C. elegans
C0013935||embryos
C1751194||DNA damage checkpoint
C1512977||mammalian cells
C1579259||Polo-like kinase 1
C0014429||activation
C1519063||phosphorylation sites
C1579259||Polo-like kinase 1
C0014429||activation
C3893712||mitotic entry
C0012860||DNA damage
C1579259||Polo-like kinase 1
C0014429||activation
C2353085||Bora
C1158886||phosphorylation
C2353787||Cdk1
C1579259||Polo-like kinase 1
C0334227||cancer cells
C0278252||poor prognosis
C2353085||Bora
C1579259||Polo-like kinase 1
C0014429||activation
C0087111||therapeutical approaches